THIOBARBITAL Synthesis, SAR, MCQ,Structure,Chemical Properties and Therapeutic Uses

Thiobarbital

IUPAC nomenclature

5,5-diethyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione

Classification

Thiobarbital is a barbiturate sedative-hypnotic.

 

Physiochemical Properties

S. NO. PHYSICAL AND CHEMICAL PROPERTIES
1 Molecular weight 200.26 g/mol
2 Physical appearance Solid
3 Melting point 180°C
4 Octanol/water partition coefficient LogP = 1.5
5 Presence of ring Pyrimidine
6 Number of chiral centers Not present
 

 

Mechanism of Action

i. Drug binds with different binding sites associated with chloride ionopore at the GABAA

ii. This results in increase in the duration of time for the opening of the chloride ionopore.

iii. As a result, the post synaptic inhibitory effect of GABA in the thalamus is prolonged.

 

Structure Activity Relationship

  • Tri-keto form is most stable in aqueous solution.
  • 4,6-dialcoholic tautomeric forms are least stable in aqueous solution.
  • 5,5-disubstituted barbituric acid is the prime requirement for the barbiturates to be sedative hypnotics.
  • Esterification of either of the 1,3-diazine nitrogens decreases hypnotic activity.
  • Substitution of either of the 1,3-diazine nitrogens with aliphatic carbons retains the anticonvulsive properties.
  • Esterification of the 5th-position substituents yields agents with analgesic activity but with weak hypnotic properties.
  • Introduction of the polar functional group at the 5th– position yields compounds which are fully devoid of sedative-hypnotic or anticonvulsive activity.
  • As the number of carbons at R2 carbon increases, the lipophillicity of the drug increases.
  • Modification of the 2nd-position oxygen of the barbiturate backbone with sulfur atom yields thiobarbiturate derivatives with increased lipophillicity, shorter duration of action, faster time of onset compared to oxy-derivative. [1]

 

Method of synthesis

Thiobarbital can be synthesized by reaction of barbital with phosphorous pentasulfide.

Therapeutic Uses

Thiobarbital is used for:

  • Central nervous system depression

 

Side Effects

Side effects of Thiobarbital are:

  • Confusion
  • Respiratory problems
  • Lack of coordination
  • Headache
  • Vomiting
  • Memory weakness

 

MCQ

 Q.1 Thiobarbital potentiates GABA receptors, which results in?

a) Increase in opening duration of chloride ion channels

b) Decrease in opening duration of chloride ion channels

c) Decrease in binding affinity of GABA

d) Both b) and c)

Q.2 Therapeutic use of drug Thiobarbital is/are?

a) CNS depression

b) Arrhythmia treatment

c) Hypertension

d) All of the above

Q.3 Which amongst the following are the correct statements with respect to the SAR of drug Thiobarbital

I. As the number of carbons at R2 carbon increases, the lipophillicity of the drug decreases

II. Introduction of the polar functional group at the 5th– position yields compounds which are fully devoid of sedative-hypnotic or anticonvulsive activity 

III. Esterification of the 5th-position substituents yields agents with analgesic activity and strong hypnotic properties..

IV. Substitution of either of the 1,3-diazine nitrogens with aliphatic carbons retains the anticonvulsive properties..

a) I, III

b) II, IV

c) I, II

d) III, IV

Q.4 The starting chemicals required for the synthesis of drug Thiobarbital?

a) Phosphorous pentasulfide

b) Barbital

c) Both a) and b)

d) None of the above

Q.5 Correct sequence for the True/False for the physiochemical properties of the drug thiobarbital is?

I. Molecular weight is 300.2 g/mol

II. It is present form

III. Melting point is 180oC

IV. 1 chiral carbons are present in the structure of barbital.

a) TFTF

b) TFFF

c) FFFT

d)FTTF

Q.6 Correct statements for the IUPAC nomenclatures of the drugs are?

I. Thiobarbital: 5,5-diethylpyrimidine-2,4,6(1H,3H,5H)-trione.

II. Amobarbital: 5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione

III. Thiamylal: 5-butan-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione

IV. Phenobarbital : 5-Ethyl-5-phenyl-1,3-diazinane-2,4,6-trione

a) II, III

b) II, IV

c) I, II, IV

d) I, III

 Q.7 Match the following drugs with their correct classifications-

i. Phenylpropanolamine A. Barbiturate sedative-hypnotic
ii. Methyldopa B. Mixed-acting sympathomimetics
iii. Thiobarbital C. Nonselective adrenergic antagonist
iv. Phenoxybenzamine D. Selective α2-adrenergic agonist

a) i-A, ii-B, iii-C, iv-D

b) i-B, ii-D, iii-A, iv-C

c) i-A, ii-D, iii-C, iv-B

d) i-C, ii-A, iii-B, iv-D

 

For More Standard and Quality Question Bank you can Join Our Test Series Programme for GPAT, NIPER JEE, Pharmacist Recruitment Exam, Drug Inspector Recruitment Exams, PhD Entrance Exam for Pharmacy

Participate in Online FREE  GPAT  TEST: CLICK HERE

  Participate in Online FREE  Pharmacist  TEST: CLICK HERE 

Participate in Online FREE  Drug Inspector  TEST: CLICK HERE 

 

 

ANSWERS

1-a

2-a

3-b

4-c

5-d

6-b

7-b

 

REFERENCES

[1] Lemke TL, Zito SW, Roche VF, Williams DA. Essentials of Foye’s principles of medicinal chemistry. Wolters Kluwer; 2017, 490-91

 

Leave a Reply

Your email address will not be published. Required fields are marked *

18 + 8 =

Designed & Developed by ThemeXpert